MDA Awards $120000 to Catabasis Pharmaceuticals MarketWatch (press release) In a previous MDA-supported mouse study, the compound was compared with the corticosteroid prednisolone (similar to prednisone). In the study, CAT-1004 worked as well as prednisolone at reducing muscle inflammation without the prednisolone side effect ... |
